Importantly, cancer patients treated with chemotherapy exhibit decreased risk of AD (Musicco et al., 2013), and an anticancer inhibitor of EGFR improves cognitive function in AD model mice (Wang et al., 2012). The gene discussed is EGFR; the disease is Alzheimer disease.